Bunge Reports Fourth Quarter Net Income of $2... (with a valuablesupply of fertilizer raw ...)

Bunge Reports Fourth Quarter Net Income of $245 Million

Date:2/7/2008

with a valuable supply of fertilizer raw materials and products. Construction on the venture's production facilities is well underway, and we expect initial phosphoric acid capacity to come online later this year. We are pleased with how our asset network is growing and becoming more balanced across geography and products."

Fourth Quarter Results

Agribusiness Operating Profit

Results increased in most regions and areas of the business. Improved performance in South America and North America were driven by higher oilseed processing and grain origination margins and volumes. Higher distribution results were due to strong global demand and improved margins. Risk management strategies performed well during a volatile quarter.

Fourth quarter results included $25 million of impairment and restructuring charges relating to the closure of oilseed processing facilities in Europe and the U.S. The closure of the European processing plant is a continuation of our strategy to improve the efficiency of our asset footprint in Eastern Europe. The U.S. processing facility was older and high cost. The attached grain elevator will continue to operate.

Fertilizer Operating Profit

The strong performance in fertilizer was due to higher margins, which benefited from higher international fertilizer prices. Selling prices in South America are based on international prices and include the cost of transportation and other import costs. As expected, demand for fertilizer products slowed in the fourth quarter after above trend-line volume growth in the first half of the year, when farmers accelerated purchases because of favorable agricultural commodity prices and concerns about increasing crop input costs.

Fourth quarter results included a $50 million increase in our value-added- tax provision, resulting from a change in tax laws in several Brazilian states that will take effect in 2008 and will make the recoverability of these taxes uncertain.
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Related biology technology :

1. Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months
2. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
3. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
4. Recent Research Reports and Near-Term Corporate Events
5. Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
6. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
7. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
8. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
9. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
10. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
11. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%

Post Your Comments:

Bunge Reports Fourth Quarter Net Income of $2...(with a valuablesupply of fertilizer raw ...)